Drug maker Dr Reddy's Laboratories’s Mexican arm has received a warning letter from the US health regulator for violation of current goods manufacturing practice regulations. Industrias Quimicas Falcon de Mexico SA has received a warning letter -- on four counts -- from the US Food and Drug Administration (USFDA). The four counts include non-validation of analytical methods used to test APIs.
The company's Mexico facility produces intermediates and active pharmaceutical ingredients.The USFDA had inspected Dr Reddy's Mexico facility in November 2010 and later sought certain explanations from the company. However, the regulator issued the warning letter dated June 3, citing 'lack of corrective actions' by the firm.
The pharmaceutical services and active ingredients business accounted for a little more than a fourth of Dr. Reddy's consolidated sales of Rs 74.69 billion in the last fiscal year ended March 31. North America contributed 16% of this business segment's sales.crackcrack
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: